Goldman Sachs’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,773,811
| Closed | -$2.46M | – | 6446 |
|
|
2022
Q4 | $2.46M | Sell |
2,773,811
-236,329
| -8% | -$313K | ﹤0.01% | 3781 |
|
|
2022
Q3 | $4.73M | Buy |
3,010,140
+1,070,161
| +55% | +$2.43M | ﹤0.01% | 3179 |
|
|
2022
Q2 | $3.9M | Buy |
1,939,979
+362,913
| +23% | +$627K | ﹤0.01% | 3394 |
|
|
2022
Q1 | $3.67M | Buy |
1,577,066
+944,285
| +149% | +$2.95M | ﹤0.01% | 3637 |
|
|
2021
Q4 | $2.94M | Buy |
632,781
+35,015
| +6% | +$217K | ﹤0.01% | 3909 |
|
|
2021
Q3 | $4.56M | Buy |
597,766
+20,023
| +3% | +$170K | ﹤0.01% | 3442 |
|
|
2021
Q2 | $5.6M | Sell |
577,743
-79,630
| -12% | -$634K | ﹤0.01% | 3234 |
|
|
2021
Q1 | $5.44M | Sell |
657,373
-1,251,900
| -66% | -$13.2M | ﹤0.01% | 3063 |
|
|
2020
Q4 | $13M | Buy |
1,909,273
+737,721
| +63% | +$5.93M | ﹤0.01% | 2237 |
|
|
2020
Q3 | $13.1M | Buy |
1,171,552
+394,791
| +51% | +$3.61M | ﹤0.01% | 2082 |
|
|
2020
Q2 | $4.88M | Sell |
776,761
-244,105
| -24% | -$935K | ﹤0.01% | 2815 |
|
|
2020
Q1 | $1.88M | Buy |
1,020,866
+811,409
| +387% | +$2.34M | ﹤0.01% | 3347 |
|
|
2019
Q4 | $708K | Buy |
209,457
+131,898
| +170% | +$314K | ﹤0.01% | 4324 |
|
|
2019
Q3 | $166K | Sell |
77,559
-705
| -0.9% | -$1.64K | ﹤0.01% | 4867 |
|
|
2019
Q2 | $209K | Sell |
78,264
-33,890
| -30% | -$122K | ﹤0.01% | 4774 |
|
|
2019
Q1 | $533K | Sell |
112,154
-13,566
| -11% | -$35.6K | ﹤0.01% | 4390 |
|
|
2018
Q4 | $301K | Sell |
125,720
-130,430
| -51% | -$426K | ﹤0.01% | 4635 |
|
|
2018
Q3 | $1.13M | Buy |
256,150
+160,147
| +167% | +$888K | ﹤0.01% | 3980 |
|
|
2018
Q2 | $691K | Sell |
96,003
-376,279
| -80% | -$2.56M | ﹤0.01% | 4310 |
|
|
2018
Q1 | $2.43M | Buy |
472,282
+439,579
| +1,344% | +$3.13M | ﹤0.01% | 3461 |
|
|
2017
Q4 | $124K | Buy |
32,703
+26,736
| +448% | +$69.6K | ﹤0.01% | 5663 |
|
|
2017
Q3 | $10K | Sell |
5,967
-265,723
| -98% | -$488K | ﹤0.01% | 6533 |
|
|
2017
Q2 | $543K | Buy |
271,690
+251,078
| +1,218% | +$490K | ﹤0.01% | 5029 |
|
|
2017
Q1 | $81K | Buy |
20,612
+8,345
| +68% | +$41.8K | ﹤0.01% | 6151 |
|
|
2016
Q4 | $60K | Sell |
12,267
-390
| -3% | -$2.34K | ﹤0.01% | 6338 |
|
|
2016
Q3 | $98K | Buy |
12,657
+2,937
| +30% | +$19.8K | ﹤0.01% | 6236 |
|
|
2016
Q2 | $54K | Buy |
9,720
+1,819
| +23% | +$11.6K | ﹤0.01% | 6403 |
|
|
2016
Q1 | $43K | Buy |
7,901
+2,857
| +57% | +$16.6K | ﹤0.01% | 6499 |
|
|
2015
Q4 | $44K | Sell |
5,044
-3,052
| -38% | -$25.7K | ﹤0.01% | 6609 |
|
|
2015
Q3 | $68K | Sell |
8,096
-9,372
| -54% | -$149K | ﹤0.01% | 6666 |
|
|
2015
Q2 | $308K | Sell |
17,468
-13,232
| -43% | -$170K | ﹤0.01% | 5716 |
|
|
2015
Q1 | $355K | Buy |
+30,700
| New | +$355K | ﹤0.01% | 5483 |
|
|
2014
Q3 | – | Sell |
-15,167
| Closed | -$102K | – | 7314 |
|
|
2014
Q2 | $102K | Buy |
+15,167
| New | +$114K | ﹤0.01% | 6542 |
|
Other funds holding SRNE
PP
OCM
OFA
CGA
LCM
STB
GA
HFRG
VFA
GBWM